ArticleScience translational medicine2018

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Adel Samson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.